Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$596.92 USD

596.92
2,138,161

+3.13 (0.53%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $596.52 -0.40 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (96 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Danaher to Benefit From Business Strength Amid Headwinds

DHR stands to benefit from strength in the clinical diagnostics business, Abcam buyout and shareholder-friendly policies. Softness in the Instrument unit remains a concern.

MYGN Taps Ultima Genomics' UG 100 Platform for Advanced Clinical Tests

Myriad Genetics and Ultima Genomics to explore the latter's sequencing platform for advanced clinical tests in oncology and reproductive genomics.

Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

TMO's New ICP-MS Systems Boost Trace Element Analysis: Stock to Gain?

Thermo Fisher introduces the iCAP MX Series ICP-MS to simplify trace elemental analysis.

Should You Continue to Hold TMO Stock in Your Portfolio?

Thermo Fisher advances in its growth strategy, supported by its wave of innovations. However, macroeconomic issues escalate expenses.

Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report?

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

TMO Stock Likely to Gain From New International CorEvitas AD Registry

Thermo Fisher launches international CorEvitas clinical registry in adolescent AD.

TMO Stock Gains From Innovation Amid Macroeconomic Issues

Thermo Fisher's business strategy involves expansion through strategic acquisition of technologies and businesses that boost its existing products and services.

TMO Stock to Gain From Expanded Bioanalytical Services in Sweden

Thermo Fisher's PPD arm unveils a new facility in Sweden, expanding its bioanalytical capabilities.

The Zacks Analyst Blog Highlights JPMorgan Chase, Thermo Fisher, Arista Networks, United Homes Group and GSI

JPMorgan Chase, Thermo Fisher, Arista Networks, United Homes Group and GSI are included in this Analyst Blog.

Mark Vickery headshot

Top Research Reports for JPMorgan, Thermo Fisher & Arista Networks

Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Thermo Fisher Scientific Inc. (TMO) and Arista Networks, Inc. (ANET), as well as two micro-cap stocks United Homes Group, Inc. (UHG) and GSI Technology, Inc. (GSIT).

Why Is Thermo Fisher (TMO) Up 1.6% Since Last Earnings Report?

Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Reasons to Retain Thermo Fisher (TMO) in Your Portfolio Now

Strategic alliances and impressive product launches bode well for Thermo Fisher (TMO).

Sheraz Mian headshot

Top Analyst Reports for Apple, NVIDIA & Coca-Cola

Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), NVIDIA Corporation (NVDA) and The Coca-Cola Company (KO), as well as two micro-cap stocks Star Group, L.P. (SGU) and Aware, Inc. (AWRE).

Quest Diagnostics' (DGX) New Study Exposes Alarming Data on STI

Quest Diagnostics' (DGX) joint study with the University of Alabama finds pregnant women undertested for STIs, raising serious concerns on maternal and newborn health.

Thermo Fisher's (TMO) CDx Gets FDA's Nod for Synovial Sarcoma

Thermo Fisher's (TMO) SeCore HLA Typing Kit gets FDA's 510(k) clearance for use as CDx with a TCR Therapy for synovial sarcoma

The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Micron Technology, KLA and Moving iMage Technologies

Thermo Fisher Scientific, Micron Technology, KLA and Moving iMage Technologies are included in this Analyst Blog.

Mark Vickery headshot

Top Research Reports for Thermo Fisher Scientific, Micron Technology & KLA

Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc. (TMO), Micron Technology, Inc. (MU) and KLA Corporation (KLAC), as well a micro-cap stock Moving iMage Technologies, Inc. (MITQ).

Company News for Jul 25, 2024

Companies in the News Are: NEE, TMO, GD, LW.

Thermo Fisher (TMO) Beats on Q2 Earnings, Raises 2024 EPS View

The year-over-year decline in Thermo Fisher's (TMO) Life Science Solutions and Laboratory Products and Biopharma Services revenues disappoints. However, margins expand in the second quarter.

Thermo Fisher (TMO) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for Thermo Fisher (TMO) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

The Zacks Analyst Blog Highlights Boston Scientific, Thermo Fisher Scientific, Align Technology and Edwards Lifesciences

Boston Scientific, Thermo Fisher Scientific, Align Technology and Edwards Lifesciences are part of the Zacks Top Analyst Blog.

Thermo Fisher Scientific (TMO) Q2 Earnings and Revenues Top Estimates

Thermo Fisher (TMO) delivered earnings and revenue surprises of 4.68% and 0.29%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

Can These 4 MedTech Stocks Hit Targets This Earnings Season?

Here is a sneak peek into how four MedTech bigshots, BSX, TMO, ALGN and EW, are expected to fare in their second-quarter results, slated to be released tomorrow.

Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for

Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.